NASDAQ : CRON
Cronos Group Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 3.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.22B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.22B |
| Enterprise Value | 459.64M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 368.41M |
| Shares Outstanding | 368.41M |
| Shares Change (YoY) | -1.58% |
| Shares Change (QoQ) | -1.76% |
| Owned by Insiders (%) | 6.75% |
| Owned by Institutions (%) | 14.41% |
| Float | 186.99M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 17.62 |
| Forward PE | 16.88 |
| PS Ratio | 6.81 |
| Forward PS | 4.69 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 24.49 |
| P/OCF Ratio | 20.31 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 6.57 |
| EV / Sales | 2.57 |
| EV / EBITDA | 38.69 |
| EV / EBIT | n/a |
| EV / FCF | 9.23 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 16.18 |
| Quick Ratio | 15.15 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 7.05% |
| Return on Assets (ROA) | -0.10% |
| Return on Invested Capital (ROIC) | -0.59% |
| Return on Capital Employed (ROCE) | -0.16% |
| Weighted Average Cost of Capital (WACC) | 10.86% |
| Revenue Per Employee | $293,585 |
| Profits Per Employee | $114,720 |
| Employee Count | 610 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.15 |
Taxes
| Measure | Value |
|---|
| Income Tax | -10.73M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +34.15% |
| 50-Day Moving Average | 3.30 |
| 200-Day Moving Average | 2.85 |
| Relative Strength Index (RSI) | 50.37 |
| Average Volume (20 Days) | 804,213 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.96M |
| Short Previous Month | 3.37M |
| Short % of Shares Out | 1.07% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 4.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 179.09M |
| Gross Profit | 77.04M |
| Operating Income | -1.84M |
| Pretax Income | 68.47M |
| Net Income | 69.98M |
| EBITDA | 11.88M |
| EBIT | -1.84M |
| Earnings Per Share (EPS) | $0.19 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 797.02M |
| Total Debt | 1.30M |
| Net Cash | 795.72M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 2.88 |
| Working Capital | 855.67M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 60.05M |
| Capital Expenditures | -10.24M |
| Depreciation & Amortization | 13.72M |
| Net Borrowing | n/a |
| Free Cash Flow | 49.82M |
| FCF Per Share | $0.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 43.02% |
| Operating Margin | -1.03% |
| Pretax Margin | 38.23% |
| Profit Margin | 39.08% |
| EBITDA Margin | 6.63% |
| EBIT Margin | -1.03% |
| FCF Margin | 27.82% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.58% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.68% |
| FCF Yield | 4.08% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.68 |
| Price Target Difference | 11.52% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 28.41% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 10.97 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |